Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Antivir Chem Chemother. 2009 Sep 25;20(1):37–46. doi: 10.3851/IMP782

Table 7.

Experimental and model-predicted concentrations of cyclopropavir (5) and “area under the curve” for oral dosing of prodrug (6).

Time, min. Exp. conc. mg/L Predicted conc. mg/L Area under the curve, AUC mg.min/L
20 15.71 157.1
40* 14.39 14.75 458.1
60* 10.17 11.94 703.7
120* 5.10 6.330 1161.8
240* 2.82 1.780 1637.0
320* 0.71 0.764 1778.2
*

Time point included in modeling of the elimination phase.